{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:28:56Z","timestamp":1769696936414,"version":"3.49.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T00:00:00Z","timestamp":1725667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-02918-3","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:02:41Z","timestamp":1725663761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Concomitant Delivery of Pirarubicin and Salinomycin Synergistically Enhanced the Efficacy of Cancer Therapy and Reduced the Risk of Cancer Relapse"],"prefix":"10.1208","volume":"25","author":[{"given":"Mohd","family":"Anees","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surender","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7082-7407","authenticated-orcid":false,"given":"Harpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,7]]},"reference":[{"issue":"2","key":"2918_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1203\/00006450-200202000-00021","volume":"51","author":"E Koh","year":"2002","unstructured":"Koh E, Ueda Y, Nakamura T, Kobayashi A, Katsuta S, Takahashi H. Apoptosis in young rats with adriamycin-induced cardiomyopathy\u2014comparison with pirarubicin, a new anthracycline derivative. Pediatr Res. 2002;51(2):256\u20139.","journal-title":"Pediatr Res"},{"issue":"1","key":"2918_CR2","first-page":"411","volume":"5","author":"S Zheng","year":"2015","unstructured":"Zheng S, Zhou S, Qiao G, Yang Q, Zhang Z, Lin F, et al. Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma. Am J Cancer Res. 2015;5(1):411.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"2918_CR3","first-page":"6063","volume":"37","author":"H Mizutani","year":"2017","unstructured":"Mizutani H, Hotta S, Nishimoto A, Ikemura K, Miyazawa D, Ikeda Y, et al. Pirarubicin, an anthracycline anticancer agent, induces apoptosis through generation of hydrogen peroxide. Anticancer Res. 2017;37(11):6063\u20139.","journal-title":"Anticancer Res"},{"key":"2918_CR4","doi-asserted-by":"crossref","unstructured":"Kunimoto S, Miura K, Takahashi Y, Takeuchi T, Umezawa H. Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin. The Journal of antibiotics. 1983;36(3):312\u20137.","DOI":"10.7164\/antibiotics.36.312"},{"key":"2918_CR5","doi-asserted-by":"crossref","unstructured":"Kunimoto S, Miura K, Umezawa K, Xu C-Z, Masuda T, Takeuchi T, et al. Cellular uptake and efflux and cytostatic activity of 4'-O-tetrahydropyranyladriamycin in adriamycin-sensitive and resistant tumor cell lines. The Journal of Antibiotics. 1984;37(12):1697\u2013702.","DOI":"10.7164\/antibiotics.37.1697"},{"key":"2918_CR6","doi-asserted-by":"crossref","unstructured":"Umezawa H, Takahashi Y, Kinoshita M, Naganawa H, Masuda T, Ishizuka M, et al. Tetrahydropyranyl derivatives of daunomycin and adriamycin. The Journal of antibiotics. 1979;32(10):1082\u20134.","DOI":"10.7164\/antibiotics.32.1082"},{"issue":"11","key":"2918_CR7","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1089\/end.2009.0680","volume":"24","author":"J Han","year":"2010","unstructured":"Han J, Lin T, Xu K, Jiang C, Huang H, Yin X, et al. Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study. J Endourol. 2010;24(11):1801\u20136.","journal-title":"J Endourol"},{"key":"2918_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.apradiso.2021.110007","volume":"179","author":"O El-Kawy","year":"2022","unstructured":"El-Kawy O, Abdelaziz G. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent. Appl Radiat Isot. 2022;179: 110007.","journal-title":"Appl Radiat Isot"},{"key":"2918_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00345-018-2196-8","volume":"36","author":"R Tanimoto","year":"2018","unstructured":"Tanimoto R, Saika T, Ebara S, Kobayashi Y, Nasu R, Yamada D, et al. Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation. World J Urol. 2018;36:889\u201395.","journal-title":"World J Urol"},{"issue":"9","key":"2918_CR10","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.3390\/cancers15092487","volume":"15","author":"Z Nie","year":"2023","unstructured":"Nie Z, Gao Y, Chen M, Peng Y, Guo N, Cao H, et al. Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer. Cancers. 2023;15(9):2487.","journal-title":"Cancers"},{"issue":"2","key":"2918_CR11","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.bbrc.2015.03.042","volume":"460","author":"K Li","year":"2015","unstructured":"Li K, Chen X, Liu C, Gu P, Li Z, Wu S, et al. Pirarubicin induces an autophagic cytoprotective response through suppression of the mammalian target of rapamycin signaling pathway in human bladder cancer cells. Biochem Biophys Res Commun. 2015;460(2):380\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"2918_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/SLA.0b013e3182300a1d","volume":"254","author":"ST Fan","year":"2011","unstructured":"Fan ST, Yang ZF, Ho DW, Ng MN, Yu WC, Wong J. Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study. Ann Surg. 2011;254(4):569\u201376.","journal-title":"Ann Surg"},{"issue":"9","key":"2918_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072843","volume":"8","author":"R Giampieri","year":"2013","unstructured":"Giampieri R, Scartozzi M, Loretelli C, Piva F, Mandolesi A, Lezoche G, et al. Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients. PLoS ONE. 2013;8(9): e72843.","journal-title":"PLoS ONE"},{"issue":"7","key":"2918_CR14","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/labinvest.2012.65","volume":"92","author":"I Martin-Padura","year":"2012","unstructured":"Martin-Padura I, Marighetti P, Agliano A, Colombo F, Larzabal L, Redrado M, et al. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts. Lab Invest. 2012;92(7):952\u201366.","journal-title":"Lab Invest"},{"key":"2918_CR15","doi-asserted-by":"crossref","unstructured":"Wicha MS. Cancer stem cells and metastasis: lethal seeds. AACR; 2006. p. 5606\u20137.","DOI":"10.1158\/1078-0432.CCR-06-1537"},{"key":"2918_CR16","doi-asserted-by":"crossref","unstructured":"Peitzsch C, Tyutyunnykova A, Pantel K, Dubrovska A, editors. Cancer stem cells: The root of tumor recurrence and metastases. Seminars in cancer biology; 2017: Elsevier.","DOI":"10.1016\/j.semcancer.2017.02.011"},{"key":"2918_CR17","doi-asserted-by":"crossref","unstructured":"Sampieri K, Fodde R, editors. Cancer stem cells and metastasis. Seminars in cancer biology; 2012: Elsevier.","DOI":"10.1016\/j.semcancer.2012.03.002"},{"issue":"9","key":"2918_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.4252\/wjsc.v7.i9.1185","volume":"7","author":"DL Dragu","year":"2015","unstructured":"Dragu DL, Necula LG, Bleotu C, Diaconu CC, Chivu-Economescu M. Therapies targeting cancer stem cells: Current trends and future challenges. World journal of stem cells. 2015;7(9):1185.","journal-title":"World journal of stem cells"},{"issue":"1","key":"2918_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gde.2003.11.007","volume":"14","author":"M Al-Hajj","year":"2004","unstructured":"Al-Hajj M, Becker MW, Wicha M, Weissman I, Clarke MF. Therapeutic implications of cancer stem cells. Curr Opin Genet Dev. 2004;14(1):43\u20137.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"2918_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25(1):1\u201318.","journal-title":"J Biomed Sci"},{"key":"2918_CR21","doi-asserted-by":"crossref","unstructured":"Borah A, Raveendran S, Rochani A, Maekawa T, Kumar D. Targeting self-renewal pathways in cancer stem cells: clinical implications for cancer therapy. Oncogenesis. 2015;4(11):e177-e.","DOI":"10.1038\/oncsis.2015.35"},{"issue":"12","key":"2918_CR22","doi-asserted-by":"publisher","first-page":"16636","DOI":"10.3390\/ijms131216636","volume":"13","author":"W Jiang","year":"2012","unstructured":"Jiang W, Peng J, Zhang Y, Cho WC, Jin K. The implications of cancer stem cells for cancer therapy. Int J Mol Sci. 2012;13(12):16636\u201357.","journal-title":"Int J Mol Sci"},{"key":"2918_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.gene.2018.09.052","volume":"681","author":"A Ku\u015fo\u011flu","year":"2019","unstructured":"Ku\u015fo\u011flu A, Avc\u0131 \u00c7B. Cancer stem cells: A brief review of the current status. Gene. 2019;681:80\u20135.","journal-title":"Gene"},{"issue":"3","key":"2918_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012;21(3):283\u201396.","journal-title":"Cancer Cell"},{"issue":"3","key":"2918_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang DG. Understanding cancer stem cell heterogeneity and plasticity. Cell Res. 2012;22(3):457\u201372.","journal-title":"Cell Res"},{"issue":"1","key":"2918_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-017-0600-4","volume":"16","author":"PR Prasetyanti","year":"2017","unstructured":"Prasetyanti PR, Medema JP. Intra-tumor heterogeneity from a cancer stem cell perspective. Mol Cancer. 2017;16(1):1\u20139.","journal-title":"Mol Cancer"},{"issue":"3","key":"2918_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5483\/BMBRep.2017.50.3.222","volume":"50","author":"K Eun","year":"2017","unstructured":"Eun K, Ham SW, Kim H. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting. BMB Rep. 2017;50(3):117.","journal-title":"BMB Rep"},{"key":"2918_CR28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-12-387688-1.00009-0","volume":"112","author":"A Pietras","year":"2011","unstructured":"Pietras A. Cancer stem cells in tumor heterogeneity. Adv Cancer Res. 2011;112:255\u201381.","journal-title":"Adv Cancer Res"},{"issue":"3","key":"2918_CR29","doi-asserted-by":"publisher","first-page":"101042831769503","DOI":"10.1177\/1010428317695035","volume":"39","author":"J Dewangan","year":"2017","unstructured":"Dewangan J, Srivastava S, Rath SK. Salinomycin: A new paradigm in cancer therapy. Tumor Biology. 2017;39(3):1010428317695035.","journal-title":"Tumor Biology"},{"issue":"4","key":"2918_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009;138(4):645\u201359.","journal-title":"Cell"},{"issue":"3","key":"2918_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1747-0285.2011.01287.x","volume":"79","author":"A Huczynski","year":"2012","unstructured":"Huczynski A. Salinomycin\u2013a new cancer drug candidate. Chem Biol Drug Des. 2012;79(3):235\u20138.","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"2918_CR32","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/10717544.2019.1580799","volume":"26","author":"J Zhou","year":"2019","unstructured":"Zhou J, Sun M, Jin S, Fan L, Zhu W, Sui X, et al. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Delivery. 2019;26(1):281\u20139.","journal-title":"Drug Delivery"},{"issue":"1","key":"2918_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-13-490","volume":"13","author":"S-T Liffers","year":"2013","unstructured":"Liffers S-T, Tilkorn DJ, Stricker I, Junge CG, Al-Benna S, Vogt M, et al. Salinomycin increases chemosensitivity to the effects of doxorubicin in soft tissue sarcomas. BMC Cancer. 2013;13(1):1\u20139.","journal-title":"BMC Cancer"},{"issue":"3","key":"2918_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2478\/intox-2014-0024","volume":"7","author":"J Ashrafihelan","year":"2014","unstructured":"Ashrafihelan J, Eisapour H, Erfani AM, Kalantary AA, Amoli JS, Mozafari M. High mortality due to accidental salinomycin intoxication in sheep. Interdiscip Toxicol. 2014;7(3):173\u20136.","journal-title":"Interdiscip Toxicol"},{"issue":"10","key":"2918_CR35","first-page":"1143","volume":"51","author":"A Omidi","year":"2010","unstructured":"Omidi A, Aslani MR, Movassaghi AR, Mohri M, Dadfar M. Accidental salinomycin intoxication in calves. Can Vet J. 2010;51(10):1143.","journal-title":"Can Vet J"},{"issue":"4","key":"2918_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00580-008-0726-2","volume":"17","author":"A Khodakaram Tafti","year":"2008","unstructured":"Khodakaram Tafti A, Nazifi S, Rajaian H, Sepehrimanesh M, Poorbaghi SL, Mohtarami S. Pathological changes associated with experimental salinomycin toxicosis in sheep. Comp Clin Pathol. 2008;17(4):255\u20138.","journal-title":"Comp Clin Pathol"},{"issue":"1\u20132","key":"2918_CR37","first-page":"675","volume":"528","author":"M Khalid","year":"2017","unstructured":"Khalid M, El-Sawy HS. Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm. 2017;528(1\u20132):675\u201391.","journal-title":"Int J Pharm"},{"issue":"7","key":"2918_CR38","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/nano10071403","volume":"10","author":"B Begines","year":"2020","unstructured":"Begines B, Ortiz T, P\u00e9rez-Aranda M, Mart\u00ednez G, Merinero M, Arg\u00fcelles-Arias F, et al. Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials. 2020;10(7):1403.","journal-title":"Nanomaterials"},{"key":"2918_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.601626","volume":"12","author":"A Gagliardi","year":"2021","unstructured":"Gagliardi A, Giuliano E, Venkateswararao E, Fresta M, Bulotta S, Awasthi V, et al. Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol. 2021;12: 601626.","journal-title":"Front Pharmacol"},{"key":"2918_CR40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ijbiomac.2019.07.220","volume":"139","author":"Y Zheng","year":"2019","unstructured":"Zheng Y, Lv X, Xu Y, Cheng X, Wang X, Tang R. pH-sensitive and pluronic-modified pullulan nanogels for greatly improved antitumor in vivo. Int J Biol Macromol. 2019;139:277\u201389.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"2918_CR41","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1021\/mp500298q","volume":"11","author":"DY Alakhova","year":"2014","unstructured":"Alakhova DY, Kabanov AV. Pluronics and MDR reversal: an update. Mol Pharm. 2014;11(8):2566\u201378.","journal-title":"Mol Pharm"},{"issue":"12","key":"2918_CR42","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1054\/bjoc.2001.2165","volume":"85","author":"E Batrakova","year":"2001","unstructured":"Batrakova E, Li S, Elmquist W, Miller D, Alakhov VY, Kabanov A. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion. Br J Cancer. 2001;85(12):1987\u201397.","journal-title":"Br J Cancer"},{"issue":"2","key":"2918_CR43","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","volume":"130","author":"EV Batrakova","year":"2008","unstructured":"Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008;130(2):98\u2013106.","journal-title":"J Control Release"},{"issue":"5","key":"2918_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0169-409X(02)00047-9","volume":"54","author":"AV Kabanov","year":"2002","unstructured":"Kabanov AV, Batrakova EV, Alakhov VY. Pluronic\u00ae block copolymers for overcoming drug resistance in cancer. Adv Drug Deliv Rev. 2002;54(5):759\u201379.","journal-title":"Adv Drug Deliv Rev"},{"key":"2918_CR45","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.ijbiomac.2021.05.096","volume":"183","author":"X Xu","year":"2021","unstructured":"Xu X, Xue Y, Fang Q, Qiao Z, Liu S, Wang X, et al. Hybrid nanoparticles based on ortho ester-modified pluronic L61 and chitosan for efficient doxorubicin delivery. Int J Biol Macromol. 2021;183:1596\u2013606.","journal-title":"Int J Biol Macromol"},{"key":"2918_CR46","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.colsurfb.2013.06.019","volume":"111","author":"XY Xiong","year":"2013","unstructured":"Xiong XY, Li QH, Li YP, Guo L, Li ZL, Gong YC. Pluronic P85\/poly (lactic acid) vesicles as novel carrier for oral insulin delivery. Colloids Surf, B. 2013;111:282\u20138.","journal-title":"Colloids Surf, B"},{"issue":"1","key":"2918_CR47","first-page":"1","volume":"1","author":"P Dehghankelishadi","year":"2016","unstructured":"Dehghankelishadi P, Dorkoosh F. Pluronic based nano-delivery systems; Prospective warrior in war against cancer. Nanomedicine Research Journal. 2016;1(1):1\u20137.","journal-title":"Nanomedicine Research Journal"},{"issue":"8","key":"2918_CR48","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/ed100461v","volume":"88","author":"JU Izunobi","year":"2011","unstructured":"Izunobi JU, Higginbotham CL. Polymer molecular weight analysis by 1H NMR spectroscopy. J Chem Educ. 2011;88(8):1098\u2013104.","journal-title":"J Chem Educ"},{"issue":"11","key":"2918_CR49","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1016\/j.polymdegradstab.2006.05.009","volume":"91","author":"M Stefani","year":"2006","unstructured":"Stefani M, Coudane J, Vert M. In vitro ageing and degradation of PEG\u2013PLA diblock copolymer-based nanoparticles. Polym Degrad Stab. 2006;91(11):2554\u20139.","journal-title":"Polym Degrad Stab"},{"issue":"9","key":"2918_CR50","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.eurpolymj.2005.04.006","volume":"41","author":"W Zhu","year":"2005","unstructured":"Zhu W, Wang B, Zhang Y, Ding J. Preparation of a thermosensitive and biodegradable microgel via polymerization of macromonomers based on diacrylated Pluronic\/oligoester copolymers. Eur Polymer J. 2005;41(9):2161\u201370.","journal-title":"Eur Polymer J"},{"issue":"5","key":"2918_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/02652048.2011.576784","volume":"28","author":"H Asadi","year":"2011","unstructured":"Asadi H, Rostamizadeh K, Salari D, Hamidi M. Preparation of biodegradable nanoparticles of tri-block PLA\u2013PEG\u2013PLA copolymer and determination of factors controlling the particle size using artificial neural network. J Microencapsul. 2011;28(5):406\u201316.","journal-title":"J Microencapsul"},{"key":"2918_CR52","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.colsurfb.2019.01.012","volume":"176","author":"N Varga","year":"2019","unstructured":"Varga N, Hornok V, Janov\u00e1k L, D\u00e9k\u00e1ny I, Csap\u00f3 E. The effect of synthesis conditions and tunable hydrophilicity on the drug encapsulation capability of PLA and PLGA nanoparticles. Colloids Surf, B. 2019;176:212\u20138.","journal-title":"Colloids Surf, B"},{"issue":"1","key":"2918_CR53","first-page":"2302","volume":"28","author":"A Patel","year":"2024","unstructured":"Patel A, Pimpalshende PM, Afzal SA, Panda J, Mohankumar M, Begum T, et al. Fabrication, Characterization and Cytotoxic Evaluation of Docetaxel Loaded Plga Nanoparticles Using Novel Polymer Pluronic F127 as Surfactant. NATURALISTA CAMPANO. 2024;28(1):2302\u201312.","journal-title":"NATURALISTA CAMPANO"},{"issue":"1","key":"2918_CR54","first-page":"157","volume":"18","author":"B-K Kim","year":"2009","unstructured":"Kim B-K, Lee J-S, Oh J-K, Park D-J. Preparation of resveratrol-loaded poly (\u03b5-caprolactone) nanoparticles by oil-in-water emulsion solvent evaporation method. Food science and biotechnology. 2009;18(1):157\u201361.","journal-title":"Food science and biotechnology"},{"issue":"2","key":"2918_CR55","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejpb.2008.08.013","volume":"71","author":"H Yin","year":"2009","unstructured":"Yin H, Bae YH. Physicochemical aspects of doxorubicin-loaded pH-sensitive polymeric micelle formulations from a mixture of poly (L-histidine)-b-poly (L-lactide)-b-poly (ethylene glycol). Eur J Pharm Biopharm. 2009;71(2):223\u201330.","journal-title":"Eur J Pharm Biopharm"},{"issue":"6","key":"2918_CR56","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1177\/0885328217741522","volume":"32","author":"L Cao","year":"2018","unstructured":"Cao L, Xiao Y, Lu W, Liu S, Gan L, Yu J, et al. Nanomicelle drug with acid-triggered doxorubicin release and enhanced cellular uptake ability based on mPEG-graft-poly (N-(2-aminoethyl)-L-aspartamide)-hexahydrophthalic acid copolymers. J Biomater Appl. 2018;32(6):826\u201338.","journal-title":"J Biomater Appl"},{"key":"2918_CR57","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.carbpol.2016.08.031","volume":"154","author":"CM Abreu","year":"2016","unstructured":"Abreu CM, Paula HC, Seabra V, Feitosa JP, Sarmento B, de Paula RC. Synthesis and characterization of non-toxic and thermo-sensitive poly (N-isopropylacrylamide)-grafted cashew gum nanoparticles as a potential epirubicin delivery matrix. Carbohyd Polym. 2016;154:77\u201385.","journal-title":"Carbohyd Polym"},{"key":"2918_CR58","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ijbiomac.2021.03.011","volume":"179","author":"IS Ribeiro","year":"2021","unstructured":"Ribeiro IS, Pontes FJ, Carneiro MJ, Sousa NA, Pinto VP, Ribeiro FO, et al. Poly (\u03b5-caprolactone) grafted cashew gum nanoparticles as an epirubicin delivery system. Int J Biol Macromol. 2021;179:314\u201323.","journal-title":"Int J Biol Macromol"},{"key":"2918_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5246\/jcps.2018.02.008","volume":"27","author":"J Zhang","year":"2018","unstructured":"Zhang J, Luo Q, Xu J, Bai J, Liu L, Mu L, et al. A derivatization method to improve the assay of salinomycin sodium and its application in the liposomal formulation. J Chin Pharm Sci. 2018;27:75\u201381. https:\/\/doi.org\/10.5246\/jcps.2018.02.008.","journal-title":"J Chin Pharm Sci"},{"issue":"4","key":"2918_CR60","first-page":"701","volume":"67","author":"JT Goras","year":"1984","unstructured":"Goras JT, Lacourse WR. Liquid chromatographic determination of sodium salinomycin in feeds, with post-column reaction. J Assoc Off Anal Chem. 1984;67(4):701\u20136.","journal-title":"J Assoc Off Anal Chem"},{"issue":"10\u201312","key":"2918_CR61","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0731-7085(91)80043-9","volume":"9","author":"M Sokoli\u0107","year":"1991","unstructured":"Sokoli\u0107 M, Pokorny M. Comparative determination of salinomycin by high-performance liquid chromatography, microbiological and calorimetric methods in testing production processes and animal feed preparations. J Pharm Biomed Anal. 1991;9(10\u201312):1047\u201353.","journal-title":"J Pharm Biomed Anal"},{"issue":"16","key":"2918_CR62","doi-asserted-by":"publisher","first-page":"e00763","DOI":"10.1128\/AEM.00763-20","volume":"86","author":"H Li","year":"2020","unstructured":"Li H, Wei J, Dong J, Li Y, Li Y, Chen Y, et al. Enhanced triacylglycerol metabolism contributes to efficient oil utilization and high-level production of salinomycin in Streptomyces albus ZD11. Appl Environ Microbiol. 2020;86(16):e00763-e820.","journal-title":"Appl Environ Microbiol"},{"issue":"11","key":"2918_CR63","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.7150\/thno.23459","volume":"8","author":"W Wu","year":"2018","unstructured":"Wu W, Luo L, Wang Y, Wu Q, Dai H-B, Li J-S, et al. Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications. Theranostics. 2018;8(11):3038.","journal-title":"Theranostics"},{"issue":"1","key":"2918_CR64","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1021\/acsami.7b15978","volume":"10","author":"G Ye","year":"2018","unstructured":"Ye G, Jiang Y, Yang X, Hu H, Wang B, Sun L, et al. Smart nanoparticles undergo phase transition for enhanced cellular uptake and subsequent intracellular drug release in a tumor microenvironment. ACS Appl Mater Interfaces. 2018;10(1):278\u201389.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"25","key":"2918_CR65","doi-asserted-by":"publisher","first-page":"9239","DOI":"10.1039\/c1jm10631g","volume":"21","author":"B Chang","year":"2011","unstructured":"Chang B, Sha X, Guo J, Jiao Y, Wang C, Yang W. Thermo and pH dual responsive, polymer shell coated, magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem. 2011;21(25):9239\u201347.","journal-title":"J Mater Chem"},{"key":"2918_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-015-0086-4","volume":"13","author":"B Wang","year":"2015","unstructured":"Wang B, Yu X-C, Xu S-F, Xu M. Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma. Journal of nanobiotechnology. 2015;13:1\u201311.","journal-title":"Journal of nanobiotechnology"},{"issue":"20","key":"2918_CR67","doi-asserted-by":"publisher","first-page":"12634","DOI":"10.3390\/ijms232012634","volume":"23","author":"HW Lee","year":"2022","unstructured":"Lee HW, Seo HS, Yeom S-Y, Kim S-N, Kim CR, Park D-H, et al. Cabozantinib-Loaded PLGA Nanoparticles: A Potential Adjuvant Strategy for Surgically Resected High-Risk Non-Metastatic Renal Cell Carcinoma. Int J Mol Sci. 2022;23(20):12634.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2918_CR68","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1039\/C5BM00440C","volume":"4","author":"C Chen","year":"2016","unstructured":"Chen C, Zheng P, Cao Z, Ma Y, Li J, Qian H, et al. PEGylated hyperbranched polyphosphoester based nanocarriers for redox-responsive delivery of doxorubicin. Biomaterials science. 2016;4(3):412\u20137.","journal-title":"Biomaterials science"},{"key":"2918_CR69","volume":"73","author":"BC Evans","year":"2013","unstructured":"Evans BC, Nelson CE, Shann SY, Beavers KR, Kim AJ, Li H, et al. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. JoVE (Journal of Visualized Experiments). 2013;73: e50166.","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"5","key":"2918_CR70","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3390\/molecules29051081","volume":"29","author":"J Ding","year":"2024","unstructured":"Ding J, Su J, Luo B, Ding L. Preparation and Evaluation of Folate Modified PEG-PLLA Nanoparticles Loaded with Lycorine for Glioma Treatment. Molecules. 2024;29(5):1081.","journal-title":"Molecules"},{"issue":"23","key":"2918_CR71","doi-asserted-by":"publisher","first-page":"14845","DOI":"10.1021\/acsami.6b04737","volume":"8","author":"D Zhao","year":"2016","unstructured":"Zhao D, Xu J-Q, Yi X-Q, Zhang Q, Cheng S-X, Zhuo R-X, et al. pH-activated targeting drug delivery system based on the selective binding of phenylboronic acid. ACS Appl Mater Interfaces. 2016;8(23):14845\u201354.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1\u20132","key":"2918_CR72","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijpharm.2009.11.014","volume":"386","author":"X Zheng","year":"2010","unstructured":"Zheng X, Kan B, Gou M, Fu S, Zhang J, Men K, et al. Preparation of MPEG\u2013PLA nanoparticle for honokiol delivery in vitro. Int J Pharm. 2010;386(1\u20132):262\u20137.","journal-title":"Int J Pharm"},{"key":"2918_CR73","doi-asserted-by":"crossref","unstructured":"Chou T-C. The combination index (CI< 1) as the definition of synergism and of synergy claims. Elsevier; 2018. p. 49\u201350.","DOI":"10.1016\/j.synres.2018.04.001"},{"issue":"1","key":"2918_CR74","first-page":"97","volume":"6","author":"N Zhang","year":"2016","unstructured":"Zhang N, Fu J-N, Chou T-C. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method. Am J Cancer Res. 2016;6(1):97.","journal-title":"Am J Cancer Res"},{"key":"2918_CR75","volume":"97","author":"Y Lombardo","year":"2015","unstructured":"Lombardo Y, de Giorgio A, Coombes CR, Stebbing J, Castellano L. Mammosphere formation assay from human breast cancer tissues and cell lines. JoVE (Journal of Visualized Experiments). 2015;97: e52671.","journal-title":"JoVE (Journal of Visualized Experiments)"},{"issue":"5","key":"2918_CR76","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00262-022-03318-x","volume":"72","author":"T Qiao","year":"2023","unstructured":"Qiao T, Zhao J, Xin X, Xiong Y, Guo W, Meng F, et al. Combined pembrolizumab and bevacizumab therapy effectively inhibits non-small-cell lung cancer growth and prevents postoperative recurrence and metastasis in humanized mouse model. Cancer Immunol Immunother. 2023;72(5):1169\u201381.","journal-title":"Cancer Immunol Immunother"},{"key":"2918_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119264","volume":"217","author":"W Sun","year":"2019","unstructured":"Sun W, Du Y, Liang X, Yu C, Fang J, Lu W, et al. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy\/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer. Biomaterials. 2019;217: 119264.","journal-title":"Biomaterials"},{"key":"2918_CR78","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fbioe.2019.00259","volume":"7","author":"T Casalini","year":"2019","unstructured":"Casalini T, Rossi F, Castrovinci A, Perale G. A perspective on polylactic acid-based polymers use for nanoparticles synthesis and applications. Frontiers in bioengineering and biotechnology. 2019;7:259.","journal-title":"Frontiers in bioengineering and biotechnology"},{"issue":"1","key":"2918_CR79","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1158\/1078-0432.CCR-09-1630","volume":"16","author":"E Charafe-Jauffret","year":"2010","unstructured":"Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, et al. Aldehyde dehydrogenase 1\u2013Positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res. 2010;16(1):45\u201355.","journal-title":"Clin Cancer Res"},{"issue":"43","key":"2918_CR80","doi-asserted-by":"publisher","first-page":"30892","DOI":"10.1074\/jbc.M113.477158","volume":"288","author":"M Alam","year":"2013","unstructured":"Alam M, Ahmad R, Rajabi H, Kharbanda A, Kufe D. MUC1-C oncoprotein activates ERK\u2192 C\/EBP\u03b2 signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells. J Biol Chem. 2013;288(43):30892\u2013903.","journal-title":"J Biol Chem"},{"issue":"23","key":"2918_CR81","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-13-0877","volume":"19","author":"MA Salvador","year":"2013","unstructured":"Salvador MA, Wicinski J, Cabaud O, Toiron Y, Finetti P, Josselin E, et al. The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression. Clin Cancer Res. 2013;19(23):6520\u201331.","journal-title":"Clin Cancer Res"},{"issue":"1\u20132","key":"2918_CR82","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ejps.2012.10.025","volume":"48","author":"SV Mussi","year":"2013","unstructured":"Mussi SV, Silva RC, de Oliveira MC, Lucci CM, de Azevedo RB, Ferreira LAM. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur J Pharm Sci. 2013;48(1\u20132):282\u201390.","journal-title":"Eur J Pharm Sci"},{"issue":"39","key":"2918_CR83","doi-asserted-by":"publisher","first-page":"14385","DOI":"10.1039\/D2NR02640F","volume":"14","author":"D Gentili","year":"2022","unstructured":"Gentili D, Ori G. Reversible assembly of nanoparticles: theory, strategies and computational simulations. Nanoscale. 2022;14(39):14385\u2013432.","journal-title":"Nanoscale"},{"issue":"21","key":"2918_CR84","doi-asserted-by":"publisher","first-page":"13262","DOI":"10.1021\/acsami.6b02416","volume":"8","author":"R Zhang","year":"2016","unstructured":"Zhang R, Xing R, Jiao T, Ma K, Chen C, Ma G, et al. Carrier-free, chemophotodynamic dual nanodrugs via self-assembly for synergistic antitumor therapy. ACS Appl Mater Interfaces. 2016;8(21):13262\u20139.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"10","key":"2918_CR85","doi-asserted-by":"publisher","first-page":"3832","DOI":"10.1021\/mp400303w","volume":"10","author":"J Zhou","year":"2013","unstructured":"Zhou J, Zhang X, Li M, Wu W, Sun X, Zhang L, et al. Novel lipid hybrid albumin nanoparticle greatly lowered toxicity of pirarubicin. Mol Pharm. 2013;10(10):3832\u201341.","journal-title":"Mol Pharm"},{"key":"2918_CR86","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.rser.2017.05.143","volume":"79","author":"MA Elsawy","year":"2017","unstructured":"Elsawy MA, Kim K-H, Park J-W, Deep A. Hydrolytic degradation of polylactic acid (PLA) and its composites. Renew Sustain Energy Rev. 2017;79:1346\u201352.","journal-title":"Renew Sustain Energy Rev"},{"issue":"9","key":"2918_CR87","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/pen.25511","volume":"60","author":"NF Zaaba","year":"2020","unstructured":"Zaaba NF, Jaafar M. A review on degradation mechanisms of polylactic acid: Hydrolytic, photodegradative, microbial, and enzymatic degradation. Polym Eng Sci. 2020;60(9):2061\u201375.","journal-title":"Polym Eng Sci"},{"key":"2918_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cbi.2016.02.004","volume":"248","author":"C Zhang","year":"2016","unstructured":"Zhang C, Lu Y, Li Q, Mao J, Hou Z, Yu X, et al. Salinomycin suppresses TGF-\u03b21-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells. Chem Biol Interact. 2016;248:74\u201381.","journal-title":"Chem Biol Interact"},{"issue":"3","key":"2918_CR89","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ygyno.2013.03.005","volume":"129","author":"S Kusunoki","year":"2013","unstructured":"Kusunoki S, Kato K, Tabu K, Inagaki T, Okabe H, Kaneda H, et al. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells. Gynecol Oncol. 2013;129(3):598\u2013605.","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2918_CR90","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/embr.201338254","volume":"15","author":"D Friedmann-Morvinski","year":"2014","unstructured":"Friedmann-Morvinski D, Verma IM. Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep. 2014;15(3):244\u201353.","journal-title":"EMBO Rep"},{"issue":"6","key":"2918_CR91","doi-asserted-by":"publisher","first-page":"8381","DOI":"10.1002\/jcp.27740","volume":"234","author":"M Najafi","year":"2019","unstructured":"Najafi M, Farhood B, Mortezaee K. Cancer stem cells (CSCs) in cancer progression and therapy. J Cell Physiol. 2019;234(6):8381\u201395.","journal-title":"J Cell Physiol"},{"issue":"4","key":"2918_CR92","first-page":"644","volume":"17","author":"I Cetin","year":"2012","unstructured":"Cetin I, Topcul M. Cancer stem cells in oncology. J BUON. 2012;17(4):644\u20138.","journal-title":"J BUON"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02918-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-02918-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-02918-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:07:27Z","timestamp":1729696047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-02918-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,7]]},"references-count":92,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["2918"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-02918-3","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,7]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"211"}}